Related Experiment Videos
Topical chloramphenicol for eye infections
1Department of Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, The Chinese University of Hong Kong, 147 Argyle Street, Hong Kong.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|February 28, 2002
Summary
Topical chloramphenicol remains a cost-effective treatment for superficial eye infections globally. However, concerns about aplastic anemia have limited its use in the United States, prompting an evaluation of its risks and benefits.
Area of Science:
- Ophthalmology
- Pharmacology
- Public Health
Background:
- Topical chloramphenicol is a broad-spectrum antibiotic for superficial ocular infections.
- Its use has declined in the US due to aplastic anemia concerns since the 1960s.
- The drug remains prevalent in many other countries.
Purpose of the Study:
- To evaluate the evidence supporting and opposing the use of topical chloramphenicol.
- To assess the risk-benefit profile of this antibiotic in treating eye diseases.
Main Methods:
- Literature review of studies on topical chloramphenicol.
- Analysis of safety data, including aplastic anemia reports.
- Evaluation of efficacy in various ocular conditions.
Main Results:
- Broad-spectrum activity and low cost support its use.
- Aplastic anemia is a significant, though rare, adverse event.
- Evidence for efficacy in specific infections is presented.
Conclusions:
- Topical chloramphenicol offers a valuable, affordable treatment option for eye infections.
- Risk assessment for aplastic anemia is crucial for informed clinical decisions.
- International variations in use highlight differing risk-benefit perceptions.